CNBC: Fast Money Halftime Report
8/3/2018 4:01pm
... myla mylan,all mylan,all mylan,allergan and celgene celgene is up 15% in a month. fire is up ten lily is up ...
CNBC: Squawk on the Street
7/29/2019 1:10pm
... maybe today creates some sellers. pfizer/mylan announced a major deal combining its off-patent branded drug business with mylan terms call for mylan shareholders to own 43% of the new entity pfizer shareholders get the rest in the meantime, pfizer and mylan each had ...
CNBC: Fast Money Halftime Report
4/19/2012 4:40pm
... lexapro was too high. one question of course here is whether mylan engaged in some kind of selective disclosure. in a statement to me the company said that it's, quote, communication program is fully compliant with applicable regulations and that mylan has a ...
CNBC: Closing Bell
4/21/2015 8:07pm
... declining to accept mylan's takeover bid. this leaves mylan as a target of teva pharmaceuticals which offered over $40 billion to acquire mylan. so, again, perrigo, its board unanimously rejecting mylan's takeover bid. back to you, kelly. ...
CNBC: Fast Money
7/27/2015 9:25pm
... mylan? mylan was down double digits. long mylan, long teva which we call a texas hedge, as teva dropped their bid for mylan but was rewarded i guess, good earnings on the street. liking this. but it seems like as long as the ...
CNBC: Squawk on the Street
7/28/2009 2:04pm
... competitors in the generic drug business, mylan putting out that press release this morning saying that the allegations, the accusations that there were quality control overrides at a drug manufacturing plant according to the fda, mylan said ...
CNBC: Power Lunch
4/17/2015 6:33pm
... mylan shares are in fact spiking. teva pharmaceuticals is considering a bid for mylan. mylan has a $29 billion bid on the table for perrigo. ...
CNBC: Power Lunch
4/22/2015 6:09pm
... for mylan. mylan coming out and making an offer for perrigo. david faber saying mylan is likely to return. there's maybe an unrequited love ...
CNBC: Fast Money Halftime Report
4/19/2012 4:41pm
... say that these guys, you know, to make the accusation without knowing all the knowledge, but mylan as cheap stock trading less than ten times earnings so i think if this boils over, it's a real bad name you want to get out of but if it doesn't mylan ...
CNBC: Power Lunch
12/20/2018 6:21pm
... attention before for jacking up prices on a drug that had been out for a long time. how does that work and do you think mylan -- i don't know how you rate mylan right now but will they actually gain from this after a decade of having an underperform on mylan, recently ...
CNBC: Squawk on the Street
4/1/2015 1:21pm
... ipos. i hope they have markets starved for secondaries because we have mylan secondary, and a huge burlington -- mylan is the abbott shares. we've got like. mylan was weak. ...
CNBC: Power Lunch
7/27/2015 5:16pm
... drugs unit for $40 billion in cash and stock to mylan. at the same time, teva is withdrawing plans to buy mylan. mylan down by 14%. thanks mandy. ...
CNBC: Squawk Box
7/29/2019 12:01pm
... today. pfizer, looking to devest its market and sharing it with mylan. it's an all-stock deal each mylan share, would be ...
CNBC: Fast Money
2/5/2020 10:49pm
... i think we're going there. it's binary meg did her spot said it was 50/50 on the mylan outcome. and mylan appealings case. to guy's point on the allison heim esper drug if it comes back and is great, the stock can go ...
CNBC: Squawk on the Street
7/14/2014 1:07pm
... start. i want to get toy mylan, another tax inversion, in this case, abbott, mylan issuing 5.3 billion in stock to abbott to buy the nonu.s. developed market specialty in brand of generics ...
CNBC: Power Lunch
3/1/2017 6:27pm
... mylan is up today. we are seeing mylan trade up today, beat in the quarter and what they project for 2017, revenue growth coming in ahead of estimates from analysts. there are questions about the results, which presumably mylan ...
CNBC: Squawk on the Street
11/2/2017 1:37pm
... decline. down 73% over the last 12 months it can't go through no, it can't. of course, you always think about perrigo and teva and mylan. teva wanted to buy mylan, mylan wanted to buy perrigo. ...
CNBC: Squawk on the Street
2/27/2019 2:02pm
... watchers weight watchers, pizza, mylan, it is a mixed bag as you say. mylan, theather fresh says, listen, we did great, we did great, we did great. ...
CNBC: Street Signs
8/17/2018 8:53am
... that could mean lower prices mylan faced a lot of criticism for increasing prices over 500% over the course of ten years mylan released its own half-priced generic version of the drug ...
CNBC: Squawk on the Street
8/9/2017 1:36pm
... myla nar mylan has core business to it. those are hail mary passes left and right. mylan should have taken the teva offer and perigo should have taken the mylan offer. anybody should have taken any offer that was made when all of ...
CNBC: Squawk Alley
4/8/2015 3:36pm
... $205 a share, cash and mylan stock, mylan is saying represents a greater than 25% premium to perrigo's trading price as of the close of business on friday april 3rd. now again this is a proposal and mylan is saying in this release ...
CNBC: Closing Bell
7/27/2015 7:16pm
... mylan will be under increased pressure to make the perrigo deal happen. there is another name in this. a fifth stock and that is abbott. abbott is mylan's largest shareholder after it bought part of mylan's generalje ne sais quoigeneral ...
CNBC: Closing Bell
2/26/2019 9:59pm
... emerson. consider it solved. welcome back we've got another earnings look on mylan seema mody has it. mylan reporting earnings that missed expectations, $1.30 versus the $1.36 estimate. ...
CNBC: Squawk Box
7/29/2019 10:46am
... that with mylan. we're getting more details on the management structure we knew that mylan's current chairman robert coury would be the new head and that pfizer ceo ...
CNBC: Fast Money Halftime Report
10/4/2017 4:41pm
... not down a ton but it is the biggest drug in multiple sclerosis and mylan is beating competitors to the market. the you bought mylan today. i bought mylan, i like it i wish i would have followed some of our guys on the site ...
CNBC: Power Lunch
8/9/2017 5:27pm
... complex products and as much as i know david loves the mylan team so much, but if we look at this, it's not just mylan, it's mylan, it's essentially the entire leadership off the generic industry that's been saying the same thing, the complex products ...
CNBC: Squawk Box
7/29/2019 10:47am
... shareholders will own 57% of the new company, mylan 43% mylan shares up 26%. pfizer was up this morning the feedback i have been hearing over the weekend, the wall ...
CNBC: Squawk on the Street
9/4/2019 1:35pm
... branded and generic established medicines business called upjohn, remember the old upjohn at pfizer, with mylan, reverse morris trust so the effect it would be mylan shareholders would own 47%, and ...
CNBC: Squawk Box
8/8/2018 12:38pm
... underappreciate the strength of mylan's business that announcement came at the same time mylan released quarterly numbers. missing estimates by 15 cents. revenue also came in below forecast sorkin yes. did you talk about carl icahn ...
CNBC: Fast Money
10/2/2009 4:39am
... tab is up over 20%, year to date. then you look at watson, that's up 40%. then take a look at mylan, up 60%. today, the option activity was going out to november 17th calls in mylan. another one of the big generics. very, very reasonable priced right now when you look at this stock, over 7500 ...
CNBC: Closing Bell
7/14/2014 8:15pm
... all right, courtney, thank you. just a short time ago here on 'closing bell,' mylan's ceo, heather bresch, talked about buying abbott labs' generic drug business. the deal will enable mylan to reincorporate in the netherlands and cut its u.s. tax bill. ...
CNBC: Power Lunch
7/25/2014 5:24pm
... are you worried that perhaps the window might be missed on mylan. we have a finite opportunity here? no, that's not what i'm talking about. i'm talking about, i'm talking about a situation where mylan is acquiring, not acquiring another ...